All News
Filter News
Found 808,606 articles
-
DeliverCareRx Announces Grand Opening of New Hospice Pharmacy in Tampa, Florida
4/4/2019
New location provides pharmacy services and home delivery to its growing base of hospice patients in the Southeastern US.
-
Medigene AG: Roivant and Sinovant Launch Cytovant Sciences in Partnership with Medigene to Develop Cellular Therapies in Asia
4/4/2019
Cytovant licenses East Asian rights for a research-stage T cell receptor (TCR) against tumor antigen NY-ESO-1 as well as rights for Medigene's dendritic cell (DC) vaccine for the treatment of patients across East Asia
-
CVS Pharmacy Launches Same-Day, On-Demand Rx Delivery Nationwide
4/4/2019
6,000 locations now offer faster same-day pharmacy and expanded front-store delivery
-
U.S. FDA Approves IBRANCE® (palbociclib) for the Treatment of Men with HR+, HER2- Metastatic Breast Cancer
4/4/2019
Approval of expanded indication based predominately on real-world data
-
MagForce AG: Inauguration ceremony marks official opening of new NanoTherm Treatment Center at Independent Public Clinical Hospital No. 4 in Lublin, Poland
4/4/2019
Independent Public Clinical Hospital No. 4 in Lublin is the first hospital outside of Germany to offer NanoTherm Therapy for the treatment of brain tumor patients
-
Herbalife Nutrition Scientists and Experts Present Research and Participate at Upcoming International Nutrition and Science Conferences
4/4/2019
Herbalife Nutrition, a premier global nutrition company, announced the participation of its science and nutrition experts at upcoming, distinguished conferences around the world.
-
Notice to the media - Government of Canada to Announce Funding to Improve the Health of Canadian Men
4/4/2019
On behalf of the Honourable Ginette Petitpas Taylor, Minister of Health, Peter Fragiskatos, Member of Parliament, will announce federal support for a healthy lifestyle project that will benefit men across Canada.
-
Mitsubishi Tanabe Pharma America Announces Names Of Teens And Young Adults Chosen For Inclusion In ALSO US™ Initiative
4/4/2019
Program Fosters Use of Original Written and Visual Art to Share Experiences with Amyotrophic Lateral Sclerosis (ALS)
-
MCRA Assists Intellirod Spine™ with 1st ever Spine De Novo Decision by the FDA
4/4/2019
MCRA, LLC has announced its role in the successful granting of the first De Novo for a device intended to be used in the spine by the U.S. Food and Drug Administration on March 28, 2019.
-
AiCuris to Present Clinical Data on AIC649 against Chronic Hepatitis B at the 2019 EASL meeting, the International Liver Congress
4/4/2019
Single intravenous dose phase 1 trial showed that AIC649 was safe and well tolerated in all dose groups
-
18 Science Teachers Named District Winners in Shell Science Lab Challenge
4/4/2019
Winners Competing For Up To $93,000 in Prizes, Including a $20,000 School Science Lab Makeover Support Package
-
CVS Pharmacy Completes Rollout of Time Delay Safes in All of Its Tennessee Pharmacies
4/4/2019
New safes for controlled substances will help combat opioid epidemic in the state and reduce robbery incidents
-
NEJM Knowledge+ Awarded Grant and Launches Pain Management and Opioids Education CME Module
4/4/2019
NEJM Knowledge+ was recently awarded an educational grant from the Opioid Analgesic Risk Evaluation and Mitigation Strategies Program Companies to extend the delivery of high-quality continuing medical education to health care providers.
-
FDA issues warning letter to genomics lab for illegally marketing genetic test that claims to predict patients' responses to specific medications
4/4/2019
[04-April-2019] SILVER SPRING, Md. , April 4, 2019 /PRNewswire/ -- Today, the U.S. Food and Drug Administration issued a warning letter to Inova Genomics Laboratory (Inova) of Falls Church, Virginia , for illegally marketing certain genetic tests that have not been reviewed by the FDA for safety and effectiveness. The tests claim to predict patients' responses to specific medications based on
-
GENFIT announces Upcoming Presentations on NASH, PBC and Diagnostics at the European Association for the Study of the Liver (EASL) International Liver Congress 2019
4/4/2019
Elafibranor Phase 2 data in PBC accepted for late-breaker oral presentation
-
Medical Marijuana, Inc. and Subsidiaries Kannaway®, HempMeds® Brasil and Phyto Animal Health Announce March 2019 as the Largest Revenue Month in Company History
4/4/2019
Medical Marijuana, Inc. , the first-ever publicly traded cannabis company in the United States, announced that the company had its the largest-ever sales month in its history in March 2019.
-
Livongo for Diabetes Program Releases HIPAA-Compliant Amazon Alexa Skill
4/4/2019
Livongo announced the Livongo for Diabetes program will now leverage Amazon Alexa's voice service to offer its Members the ability to ask any of their Alexa-enabled devices to provide their blood glucose readings and health tips via the new Livongo skill.
-
KT Tape named Premier Sponsor and Official Kinesiology Tape of the NBATA
4/4/2019
The National Basketball Athletic Trainers' Association welcomes KT Tape, the leading producer of kinesiology tape and related sports performance products in the retail market, to the NBATA partnership family as the "Official Kinesiology Tape Sponsor of NBATA".
-
FDA expands approved use of metastatic breast cancer treatment to include male patients
4/4/2019
The U.S. Food and Drug Administration is extending the indication of Ibrance capsules in combination with specific endocrine therapies for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer in male patients.
-
Immunicum AB (publ) Publishes the Annual Report for 2018
4/4/2019
Immunicum AB, announced that its Annual Report for 2018 is now available on the company's website, www.immunicum.com.